A detailed history of Israel Englander (Millennium Management LLC) transactions in Compass Pathways PLC stock. As of the latest transaction made, Millennium Management LLC holds 60,000 shares of CMPS stock, worth $512,399. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,000
Previous 3,225,545 98.14%
Holding current value
$512,399
Previous $27.5 Million 98.14%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
N/A
156,521 Added 4.85%
3,382,066 $28.9 Million
Q1 2024

May 15, 2024

BUY
N/A
3,120,656 Added 2975.2%
3,225,545 $27.5 Million
Q4 2023

Feb 14, 2024

BUY
N/A
14,689 Added 16.28%
104,889 $895,000
Q2 2023

Aug 14, 2023

SELL
$7.79 - $10.69 $297,328 - $408,015
-38,168 Reduced 29.73%
90,200 $770,000
Q1 2023

May 15, 2023

BUY
$7.32 - $10.85 $62,637 - $92,843
8,557 Added 7.14%
128,368 $1.28 Million
Q4 2022

Feb 14, 2023

SELL
$7.84 - $11.68 $605,279 - $901,742
-77,204 Reduced 39.19%
119,811 $962,000
Q3 2022

Nov 14, 2022

BUY
$10.73 - $20.07 $933,746 - $1.75 Million
87,022 Added 79.12%
197,015 $2.11 Million
Q2 2022

Aug 15, 2022

SELL
$6.76 - $14.18 $130,413 - $273,560
-19,292 Reduced 14.92%
109,993 $1.19 Million
Q1 2022

May 16, 2022

BUY
$11.13 - $23.04 $368,992 - $763,845
33,153 Added 34.49%
129,285 $1.67 Million
Q4 2021

Feb 14, 2022

BUY
$21.81 - $48.96 $2.1 Million - $4.71 Million
96,132 New
96,132 $2.13 Million
Q1 2021

May 17, 2021

SELL
$34.75 - $57.5 $3.48 Million - $5.76 Million
-100,172 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$32.0 - $59.2 $816,480 - $1.51 Million
25,515 Added 34.18%
100,172 $4.77 Million
Q3 2020

Nov 16, 2020

BUY
$28.83 - $43.17 $2.15 Million - $3.22 Million
74,657 New
74,657 $2.61 Million

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.